1. Covid-19: Remdesivir has little or no impact on survival, WHO trial shows
2. Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results https://www.medrxiv.org/content/10.1101/2020.10.15.20209817v1?ijkey=481e7d4baacf42b29fabc7437bfc7eee1f97467d&keytype2=tf_ipsecsha.
3. Covid-19: US should end Gilead’s monopoly on producing remdesivir, report says
4. Veklury prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214787Orig1s000lbl.pdf.
5. Remdesivir for the Treatment of Covid-19 — Final Report